questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Phénols
Catéchols
Catécholamines
Épinéphrine
Épinéphrine : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épinéphrine : Questions médicales les plus fréquentes",
"headline": "Épinéphrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épinéphrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-25",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épinéphrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Catécholamines",
"url": "https://questionsmedicales.fr/mesh/D002395",
"about": {
"@type": "MedicalCondition",
"name": "Catécholamines",
"code": {
"@type": "MedicalCode",
"code": "D002395",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Désoxyadrénaline",
"alternateName": "Deoxyepinephrine",
"url": "https://questionsmedicales.fr/mesh/D003846",
"about": {
"@type": "MedicalCondition",
"name": "Désoxyadrénaline",
"code": {
"@type": "MedicalCode",
"code": "D003846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métanéphrine",
"alternateName": "Metanephrine",
"url": "https://questionsmedicales.fr/mesh/D008676",
"about": {
"@type": "MedicalCondition",
"name": "Métanéphrine",
"code": {
"@type": "MedicalCode",
"code": "D008676",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Racépinéfrine",
"alternateName": "Racepinephrine",
"url": "https://questionsmedicales.fr/mesh/D064705",
"about": {
"@type": "MedicalCondition",
"name": "Racépinéfrine",
"code": {
"@type": "MedicalCode",
"code": "D064705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.657.166.175.461.825"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Épinéphrine",
"alternateName": "Epinephrine",
"code": {
"@type": "MedicalCode",
"code": "D004837",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kenneth L Dretchen",
"url": "https://questionsmedicales.fr/author/Kenneth%20L%20Dretchen",
"affiliation": {
"@type": "Organization",
"name": "Mesa Science Associates, Inc., 4539 Metropolitan Ct, Frederick, MD, 21701, USA. Ken.Dretchen@MesaScience.com."
}
},
{
"@type": "Person",
"name": "Matthew Greenhawt",
"url": "https://questionsmedicales.fr/author/Matthew%20Greenhawt",
"affiliation": {
"@type": "Organization",
"name": "Section of Allergy and Immunology, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Denver, CO, USA. Electronic address: Matthew.Greenhawt@childrenscolorado.org."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Zack Mesa",
"url": "https://questionsmedicales.fr/author/Zack%20Mesa",
"affiliation": {
"@type": "Organization",
"name": "Mesa Science Associates, Inc., 4539 Metropolitan Ct, Frederick, MD, 21701, USA."
}
},
{
"@type": "Person",
"name": "Matthew Robben",
"url": "https://questionsmedicales.fr/author/Matthew%20Robben",
"affiliation": {
"@type": "Organization",
"name": "Robben Consulting LLC, Rochester, NY, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/36600424",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-067251"
}
},
{
"@type": "ScholarlyArticle",
"name": "Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35617986",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/S2213-2600(22)00088-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.",
"datePublished": "2024-08-14",
"url": "https://questionsmedicales.fr/article/39161682",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/DDDT.S472651"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of Liposomal Melatonin in sleep EEG in Childhood: A Double Blind Case Control Study.",
"datePublished": "2022-12-29",
"url": "https://questionsmedicales.fr/article/36612875",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20010552"
}
},
{
"@type": "ScholarlyArticle",
"name": "Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.",
"datePublished": "2022-06-20",
"url": "https://questionsmedicales.fr/article/35725922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41591-022-01861-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Phénols",
"item": "https://questionsmedicales.fr/mesh/D010636"
},
{
"@type": "ListItem",
"position": 8,
"name": "Catéchols",
"item": "https://questionsmedicales.fr/mesh/D002396"
},
{
"@type": "ListItem",
"position": 9,
"name": "Catécholamines",
"item": "https://questionsmedicales.fr/mesh/D002395"
},
{
"@type": "ListItem",
"position": 10,
"name": "Épinéphrine",
"item": "https://questionsmedicales.fr/mesh/D004837"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épinéphrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épinéphrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épinéphrine",
"description": "Comment diagnostiquer une anaphylaxie ?\nQuels tests sont utilisés pour évaluer l'épinéphrine ?\nQuels signes indiquent un choc anaphylactique ?\nComment évaluer une réaction allergique ?\nQuels sont les critères de diagnostic de l'anaphylaxie ?",
"url": "https://questionsmedicales.fr/mesh/D004837?mesh_terms=Double-Blind+Method&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épinéphrine",
"description": "Quels sont les symptômes d'une surdose d'épinéphrine ?\nComment reconnaître une réaction allergique ?\nQuels signes indiquent une crise d'asthme ?\nQuels symptômes nécessitent une injection d'épinéphrine ?\nQuels sont les effets secondaires de l'épinéphrine ?",
"url": "https://questionsmedicales.fr/mesh/D004837?mesh_terms=Double-Blind+Method&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épinéphrine",
"description": "Comment prévenir une réaction allergique ?\nQuelles précautions prendre avec l'épinéphrine ?\nComment éduquer sur l'utilisation de l'épinéphrine ?\nQuels sont les conseils pour les personnes allergiques ?\nComment éviter les déclencheurs d'allergies ?",
"url": "https://questionsmedicales.fr/mesh/D004837?mesh_terms=Double-Blind+Method&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épinéphrine",
"description": "Comment administrer l'épinéphrine en cas d'urgence ?\nQuelle est la posologie standard d'épinéphrine ?\nQuand répéter l'injection d'épinéphrine ?\nQuels traitements alternatifs à l'épinéphrine existent ?\nComment l'épinéphrine aide-t-elle en cas d'asthme ?",
"url": "https://questionsmedicales.fr/mesh/D004837?mesh_terms=Double-Blind+Method&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épinéphrine",
"description": "Quelles complications peuvent survenir après une injection d'épinéphrine ?\nQuels risques sont associés à une surdose d'épinéphrine ?\nComment gérer les effets secondaires de l'épinéphrine ?\nQuelles sont les conséquences d'une anaphylaxie non traitée ?\nQuels sont les effets à long terme d'une anaphylaxie ?",
"url": "https://questionsmedicales.fr/mesh/D004837?mesh_terms=Double-Blind+Method&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épinéphrine",
"description": "Quels sont les facteurs de risque d'anaphylaxie ?\nComment l'âge influence-t-il le risque d'anaphylaxie ?\nQuels médicaments augmentent le risque d'allergies ?\nComment les allergies alimentaires influencent-elles le risque ?\nQuels facteurs environnementaux peuvent aggraver les allergies ?",
"url": "https://questionsmedicales.fr/mesh/D004837?mesh_terms=Double-Blind+Method&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anaphylaxie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anaphylaxie est diagnostiquée par des symptômes cliniques et l'historique d'exposition à un allergène."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'épinéphrine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire peuvent mesurer les niveaux d'épinéphrine dans le sang en cas de besoin."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un choc anaphylactique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une difficulté respiratoire, une chute de la pression artérielle et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Comment évaluer une réaction allergique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'examen des symptômes et l'historique médical du patient."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic de l'anaphylaxie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des symptômes cutanés, respiratoires et gastro-intestinaux après exposition à un allergène."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surdose d'épinéphrine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent palpitations, anxiété, tremblements et hypertension."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent se manifester par des démangeaisons, des éruptions cutanées et un gonflement."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une crise d'asthme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une respiration sifflante, une toux persistante et une oppression thoracique."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une injection d'épinéphrine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme des difficultés respiratoires et un gonflement du visage nécessitent une injection."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de l'épinéphrine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des palpitations, des maux de tête et des nausées."
}
},
{
"@type": "Question",
"name": "Comment prévenir une réaction allergique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les allergènes connus et portez un auto-injecteur d'épinéphrine en cas d'urgence."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avec l'épinéphrine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conservez l'épinéphrine à température ambiante et vérifiez la date d'expiration régulièrement."
}
},
{
"@type": "Question",
"name": "Comment éduquer sur l'utilisation de l'épinéphrine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Formez les patients et leurs proches à reconnaître les symptômes et à administrer l'épinéphrine."
}
},
{
"@type": "Question",
"name": "Quels sont les conseils pour les personnes allergiques ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ayez toujours un auto-injecteur, informez votre entourage et portez un bracelet d'alerte médicale."
}
},
{
"@type": "Question",
"name": "Comment éviter les déclencheurs d'allergies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Identifiez et évitez les aliments, médicaments ou insectes qui provoquent des réactions."
}
},
{
"@type": "Question",
"name": "Comment administrer l'épinéphrine en cas d'urgence ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'épinéphrine est généralement administrée par injection intramusculaire dans la cuisse."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard d'épinéphrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie standard pour l'anaphylaxie est de 0,3 à 0,5 mg pour les adultes, par injection."
}
},
{
"@type": "Question",
"name": "Quand répéter l'injection d'épinéphrine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'injection peut être répétée toutes les 5 à 15 minutes si les symptômes persistent."
}
},
{
"@type": "Question",
"name": "Quels traitements alternatifs à l'épinéphrine existent ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques et des corticostéroïdes peuvent être utilisés en complément, mais pas en remplacement."
}
},
{
"@type": "Question",
"name": "Comment l'épinéphrine aide-t-elle en cas d'asthme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'épinéphrine dilate les voies respiratoires, facilitant la respiration lors d'une crise d'asthme."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une injection d'épinéphrine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des arythmies cardiaques, des douleurs thoraciques ou des réactions locales."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à une surdose d'épinéphrine ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surdose peut entraîner des complications graves comme des crises cardiaques ou des AVC."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires de l'épinéphrine ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les symptômes et consultez un médecin si les effets secondaires persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une anaphylaxie non traitée ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une anaphylaxie non traitée peut entraîner un choc, une perte de conscience et même la mort."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme d'une anaphylaxie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des troubles anxieux et des modifications du mode de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'anaphylaxie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents d'allergies, des maladies respiratoires et des expositions répétées."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque d'anaphylaxie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les jeunes enfants et les personnes âgées sont plus à risque en raison de systèmes immunitaires fragiles."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'allergies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains antibiotiques et anesthésiques peuvent augmenter le risque de réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment les allergies alimentaires influencent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les allergies alimentaires, comme celles aux arachides, augmentent le risque d'anaphylaxie."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux peuvent aggraver les allergies ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution, le pollen et les acariens peuvent exacerber les symptômes allergiques."
}
}
]
}
]
}
Sepsis is a major cause of death among hospitalised patients. Accumulating evidence suggests that immune response during sepsis cascade lies within a spectrum of dysregulated host responses. On the on...
ImmunoSep is a randomised placebo-controlled phase 2 clinical trial with a double-dummy design in which the effect of precision immunotherapy on sepsis phenotypes with MALS and immunoparalysis is stud...
The protocol is approved by the German Federal Institute for Drugs and Medical Devices; the National Ethics Committee of Greece and by the National Organization for Medicines of Greece; the Central Co...
NCT04990232....
Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone p...
In this randomised, double-blind, double placebo-controlled trial, patients were enrolled at 67 trial sites in the USA (60 sites), South Korea (two sites), Mexico (two sites), Singapore (two sites), a...
Between Dec 1, 2020, and April 13, 2021, 1047 patients were assessed for eligibility. 1010 patients were enrolled and randomly assigned, 516 (51%) to baricitinib plus remdesivir plus placebo and 494 (...
In hospitalised patients with COVID-19 requiring supplemental oxygen by low-flow, high-flow, or non-invasive ventilation, baricitinib plus remdesivir and dexamethasone plus remdesivir resulted in simi...
National Institute of Allergy and Infectious Diseases....
This study aimed to establish the 95% effective dose (ED95) of esketamine in combination with propofol for hysteroscopy and then to evaluate its efficacy and safety profile....
This prospective, double-blind, randomized controlled trial consisted of two cohorts. In cohort 1, 45 women aged 18-65 years undergoing hysteroscopy were randomly assigned to either group E (esketamin...
The ED95 of esketamine was 0.254 mg/kg (95% CI: 0.214-1.004), while that of alfentanil was 9.121 μg/kg (95% CI: 8.479-13.364). The anesthesia success rate was 93.0% in group E and 95.2% in group A (p ...
This study determined the ED 95 dose of esketamine for intravenous general anesthesia during hysteroscopy. Esketamine showed less respiratory and hemodynamic depression, as well as fewer adverse effec...
www.chictr.org.cn, (ChiCTR2300077283); registered November 3, 2023....
Electroencephalography (EEG) is pivotal in the clinical assessment of epilepsy, and sleep is known to improve the diagnostic yield of its recording. Sleep-EEG recording is generally reached by either ...
Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease that may advance to fibrosis and lead to mortality; however, no pharmacotherapy is currently available. We tested the hypothesis t...
Rescue of mitochondrial function is a promising neuroprotective strategy for Parkinson's disease (PD). Ursodeoxycholic acid (UDCA) has shown considerable promise as a mitochondrial rescue agent across...
To investigate the safety and tolerability of high-dose UDCA in PD and determine midbrain target engagement....
The UP (UDCA in PD) study was a phase II, randomized, double-blind, placebo-controlled trial of UDCA (30 mg/kg daily, 2:1 randomization UDCA vs. placebo) in 30 participants with PD for 48 weeks. The p...
UDCA was safe and well tolerated, and only mild transient gastrointestinal adverse events were more frequent in the UDCA treatment group. Midbrain...
High-dose UDCA is safe and well tolerated in early PD. Larger trials are needed to further evaluate the disease-modifying effect of UDCA in PD. © 2023 The Authors. Movement Disorders published by Wile...
To determine whether intravenous vitamin C compared with placebo, reduces vasopressor requirements in patients with vasoplegic shock....
Double-blinded, randomised clinical trial (RCT) conducted in two intensive care units in Perth, Australia. Vasopressor requirements at enrolment needed to be >10 μg/min noradrenaline after hypovolaemi...
Of the 71 patients randomised (35 vitamin C, 36 placebo group), the median vasopressor duration was 44 h [95% CI, 37-54 h] and 55 h [95% CI, 33-66 h]) in the vitamin C and placebo groups (p = 0.057). ...
In this RCT of patients with vasoplegic shock of at least moderate severity, the use of IV vitamin C compared with placebo did not significantly reduce the duration of vasopressors....
Prospective registration - trial number ACTRN12617001392358....
Fibrotic hypersensitivity pneumonitis (FHP) is an irreversible lung disease with high morbidity and mortality. We sought to evaluate the safety and effect of pirfenidone on disease progression in such...
We conducted a single-centre, randomised, double-blinded, placebo-controlled trial in adults with FHP and disease progression. Patients were assigned in a 2:1 ratio to receive either oral pirfenidone ...
After randomising 40 patients, enrolment was interrupted by the COVID-19 pandemic. There was no significant between-group difference in FVC% at week 52 (mean difference -0.76%, 95% CI -6.34 to 4.82). ...
The trial was underpowered to detect a difference in the primary end point. Pirfenidone was found to be safe and improved PFS in patients with FHP....
NCT02958917....
Pain after soft tissue injuries in and around the ankle is a troublesome process in terms of patient comfort and mobilization. The aim of this study was to compare the analgesic efficacy of intravenou...
We conducted a prospective, double-blind, randomized controlled study in a tertiary hospital. The patients were divided into two groups as those administered IV 400 mg ibuprofen and IV 20 mg tenoxicam...
One hundred and twenty-four patients were included in the study. There were 62 patients in the tenoxicam group and 62 patients in the ibuprofen group. When VAS scores were compared, it was found that ...
We hypothesize that synbiotic supplementation could modulate the intestinal microbiota and subsequently, improve the condition of hypothyroid patients....
Fifty-six adult hypothyroid patients were recruited to this double-blind, placebo-controlled, randomized clinical trial. The intervention was 10 weeks of synbiotic (500 mg of 109 CFU/g probiotics plus...
Analysis on 51 patients who completed the trial showed that TSH and depression (p> 0.05) did not change significantly, while serum FT4 significantly increased in both groups (p = 0.03 and p = 0.02 in ...
Ten-week supplementation with synbiotic had no favorable effect on depression and TSH, but it improved blood pressure and quality of life in patients with hypothyroidism. More trials are needed to sup...
IRCT20210926052583N1, Iranian Registry of Clinical Trials (IRCT), registered October 1st, 2021....